tHEORetically Speaking

INsights & OUTcomes with Chris O'Neill

HealthEconomics.com Season 4 Episode 2

Welcome to INsights & OUTcomes, the newest podcast on tHEORetically speaking from HealthEconomics.com, where we sit down with the leading professionals in HEOR, RWE, and market access, the experts shaping the future of healthcare decisions.

This episode features Chris O'Neill, founder and CEO of Bosun MA. He has has over 20 years’ experience developing and delivering value and Market Access solutions for Pharma clients at a global and regional level.

BOSUN MA has over 20 years of expertise in payer understanding, and they use the latest AI technologies to help align clinical outcomes and Payer Need. Bosun MA is a leading architect of AI SaaS tools which enable clients to develop value messages that are underpinned by clinical evidence and which can be tested systematically against the value drivers in multiple geographies and Payer environments. They work globally in all major therapeutic areas and have a rich experience in developing value strategies across all development stages: helping to drive investment decisions and launch programs.

Introducing Trial Insights—the essential tool for pharma researchers and biotech investors. 

Seamlessly track clinical trials in real-time, refine searches by key criteria, and receive timely notifications on important updates. With Trial Insights, ensure your research and business initiatives are always informed and strategically positioned for success. 

Start exploring thousands of trials today at trialinsights.com